Friday Links
Trends in cost-related non-adherence.Optum Rx reduces reauthorization requirements.Changes in insulin out-of-pocket costs over time.AI and billable hours.Value in Health to include ‘Plan Language Summaries’
Read More
Critical Care Documentation: Why It’s Different and How It Impacts Patient Care
By embracing better tools and smarter approaches, agencies can reduce the strain on their teams and give their patients the most seamless, high-quality care possible. The post Critical Care Documentation: Why It’s Different and How It Impacts Patient Care appeared first on MedCity News.
Future Trends for Clinical Trials in 2025 and Beyond
Four key predictions for the future of clinical trials, examining how these changes will revolutionize the speed, efficiency, and reliability of bringing life-saving treatments to market. The post Future Trends for Clinical Trials in 2025 and Beyond appeared first on MedCity News.
GoodRx Unveils Cost-Plus Model for Independent Pharmacies
GoodRx launched Community Link, a new cost-plus pricing program that allows independent pharmacies to contract directly with GoodRx. The post GoodRx Unveils Cost-Plus Model for Independent Pharmacies appeared first on MedCity News.
Quantifying treatment value under IRA
That is the title of my new publication out today with the subtitle “A case study of rifaximin for the treatment of overt hepatic encephalopathy using QALY and non-QALY measures“. This was work with co-authors Shanshan Wang, Leonardo Passos Chaves, Olamide Olujohungbe, Sanjana Muthukrishnan, and Aditi Chaudhary. The abstract is below. BackgroundTraditional cost effectiveness analyses…
AHA: Nonprofit Hospitals Delivered 10 Times Their Federal Tax Exemption
EY report shows a $9 increase in benefits from the prior year
Four Ways Trump’s ‘One Big Beautiful Bill’ Would Undermine Access to Obamacare
Major changes could be in store for the more than 24 million people with health coverage under the Affordable Care Act, including how and when they can enroll, the paperwork required, and, crucially, the premiums they pay. A driver behind these changes is the “One Big Beautiful Bill,” the name given to spending and tax…
AI Biotech BenevolentAI Restructures Again, This Time to Return to Its TechBio Roots
BenevolentAI said it will still develop its internally discovered drugs, but will now seek partners for them earlier in their development. Going forward, BenevolentAI will focus on making its AI technologies available to support the drug R&D efforts of its partners. The post AI Biotech BenevolentAI Restructures Again, This Time to Return to Its TechBio…
Women’s History Month Spotlight: Maureen Gremminger
Maureen Gremminger, EVS Resident Regional Manager, Inspira Health Network in Mullica Hill, New Jersey I was an office manager at a moving company before joining Crothall’s Manager in Training program in 2012. At that time, I met Joce-Lyn Hanton, who was an operations manager. She was so inspirational; she knew everything about cleaning. The first…
The Promise and Challenge of GLP-1 Medications: Ensuring ROI in Obesity Care
Pricy GLP-1 medications are here to stay — let’s focus on turning their potential into lasting, meaningful impact. The post The Promise and Challenge of GLP-1 Medications: Ensuring ROI in Obesity Care appeared first on MedCity News.